Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Aneesha Radhakrishnan"'
Autor:
Niraj Babu, Sonali Mohan, Vishalakshi Nanjappa, Sandip Chavan, Jayshree Advani, Aafaque Ahmed Khan, Santosh Renuse, Aneesha Radhakrishnan, T.S. Keshava Prasad, Rekha V. Kumar, Jay Gopal Ray, Manjusha Biswas, Saravanan Thiyagarajan, Joseph A. Califano, David Sidransky, Harsha Gowda, Aditi Chatterjee
Publikováno v:
Data in Brief, Vol 19, Iss , Pp 1124-1130 (2018)
Head and neck squamous cell carcinoma (HNSCC) is one of the most common cancers in India. Despite improvements in treatment strategy, the survival rates of HNSCC patients remain poor. Thus, it is necessary to identify biomarkers that can be used for
Externí odkaz:
https://doaj.org/article/4db0e8d158e94c5b9597842b8f8929af
Autor:
Steve Thomas Pannakal, Sibylle Jäger, Albert Duranton, Amit Tewari, Subarna Saha, Aneesha Radhakrishnan, Nita Roy, Jean François Kuntz, Soraya Fermas, Darryl James, Jane Mellor, Namita Misra, Lionel Breton
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0179813 (2017)
The traditional Indian medicine, Ayurveda, provides insights and practical solutions towards a healthy life style. Rasayana is a branch of Ayurveda known for preserving and promoting health, enhancing the quality of life and delaying the aging proces
Externí odkaz:
https://doaj.org/article/df6e3869af7a42b5bf2ea6da8203b367
Autor:
Niraj Babu, Jayshree Advani, Hitendra S. Solanki, Krishna Patel, Ankit Jain, Aafaque A. Khan, Aneesha Radhakrishnan, Nandini A. Sahasrabuddhe, P.P Mathur, Bipin Nair, Xiaofei Chang, T.S. Keshava Prasad, David Sidransky, Harsha Gowda, Aditi Chatterjee
Publikováno v:
Canadian Journal of Biotechnology, Vol 1, Iss Special Issue-Supplement, Pp 244-244 (2017)
Dysregulation of miRNAs is well associated with the development of non-small cell lung cancer (NSCLC). It is imperative that dysregulation of miRNAs by cigarette smoke will affect the expression of their targets, either leading to the activation of o
Externí odkaz:
https://doaj.org/article/75803c086dcf4f8a91dd0e01f141bf56
Autor:
Ankit P. Jain, Krishna Patel, Sneha Pinto, Vishalakshi Nanjappa, Aneesha Radhakrishnan, Anjali Kumari, Malini Manoharan, Coral Karunakaran, Saktivel Murugan, T.S. Keshava Prasad, Premendu P. Mathur, Bipin Nair, Ravi Gupta, Rohit Gupta, Arati Khanna-Gupta, David Sidransky, Aditi Chatterjee, Harsha Gowda
Publikováno v:
Canadian Journal of Biotechnology, Vol 1, Iss Special Issue, Pp 61-61 (2017)
Epidermal growth factor receptor (EGFR) is overexpressed in 90% of head and neck squamous cell carcinomas (HNSCC). However, most clinical trials with tyrosine kinase inhibitors (TKIs) have shown modest response rates due to development of acquired re
Externí odkaz:
https://doaj.org/article/867ed1f53f5643f195f8c9e5694ca41c
Autor:
Sneha M. Pinto, Thottethodi Subrahmanya Keshava Prasad, Vishalakshi Nanjappa, David Sidransky, Harsha Gowda, Aneesha Radhakrishnan, Aditi Chatterjee, Krishna Patel, Premendu P. Mathur, Ankit P. Jain, Remya Raja, Manish Kumar
Publikováno v:
OMICS
Resistance to cancer chemotherapy is a major global health burden. Epidermal growth factor receptor (EGFR) is a proven therapeutic target for multiple cancers of epithelial origin. Despite its overexpression in >90% of head and neck squamous cell car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2186ffa7c64e1406b15266c1d4bd645d
https://doi.org/10.1089/omi.2021.0057
https://doi.org/10.1089/omi.2021.0057
Autor:
Aditi Chatterjee, Pamela Leal-Rojas, Mikhail Korzinkin, Evgeny Izumchenko, Akhilesh Pandey, Tejaswini Subbannayya, Niraj Babu, Aneesha Radhakrishnan, David Sidransky, T. S. Keshava Prasad, Sneha M. Pinto, Mustafa A. Barbhuiya, Rafael Guerrero-Preston, Sandip Chavan, Rekha V. Kumar, Juan Carlos Roa, Sanjay Navani, Harsha Gowda, Pramod Kumar Tiwari, Prashant Kumar, Alex Zhavoronkov, Ivan V. Ozerov, Remya Raja, Arun H. Patil
Publikováno v:
Journal of Cell Communication and Signaling. 13:163-177
Gallbladder cancer (GBC) is a rare malignancy, associated with poor disease prognosis with a 5-year survival of only 20%. This has been attributed to late presentation of the disease, lack of early diagnostic markers and limited efficacy of therapeut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::262d5849c5834c1dcc2ff91e8400747d
https://doi.org/10.1007/s12079-018-00503-5
https://doi.org/10.1007/s12079-018-00503-5
Autor:
Hitendra S. Solanki, Remya Raja, Alex Zhavoronkov, Ivan V. Ozerov, Artem V. Artemov, Jayshree Advani, Aneesha Radhakrishnan, Niraj Babu, Vinuth N. Puttamallesh, Nazia Syed, Vishalakshi Nanjappa, Tejaswini Subbannayya, Nandini A. Sahasrabuddhe, Arun H. Patil, T.S. Keshava Prasad, Daria Gaykalova, Xiaofei Chang, Rachana Sathyendran, Premendu Prakash Mathur, Annapoorni Rangarajan, David Sidransky, Akhilesh Pandey, Evgeny Izumchenko, Harsha Gowda, Aditi Chatterjee
Publikováno v:
Oncoscience. 8:108-109
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6d1496bcba58ab630fd23b20a233790
https://doi.org/10.18632/oncoscience.546
https://doi.org/10.18632/oncoscience.546
Autor:
Saravanan Thiyagarajan, Pradip K. Majumder, Padhma Radhakrishnan, Manjusha Biswas, Govind Babu, Biplab Tewary, Aditi Chatterjee, Bipinesh Sansar, Ram Shankar Upadhayaya, Aneesha Radhakrishnan, Manoj Rajappa, Jayshree Advani, Chethan Rajegowda, Padmaparna Chaudhuri
Publikováno v:
Cancer Biol Ther
The prognosis of AML is generally poor, with 5-year survival rate of 25%. There has been substantial progress in identification of new therapeutic targets, along with approval of at least three targeted therapies for AML in recent years. Nevertheless
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cd7a504cded02ae13429c350444e1d9
https://europepmc.org/articles/PMC7834080/
https://europepmc.org/articles/PMC7834080/
Autor:
Remya Raja, Ankit P. Jain, Sneha M. Pinto, Harsha Gowda, Aneesha Radhakrishnan, Rohit Gupta, Malini Manoharan, Premendu P. Mathur, Ravi Gupta, Arun H. Patil, Xiaofei Chang, Arati Khanna-Gupta, Vishalakshi Nanjappa, Prashant Kumar, Aditi Chatterjee, Krishna Patel, David Sidransky, Anjali Kumari, Manish Kumar, Saktivel Murugan, Coral Karunakaran, T. S. Keshava Prasad
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Epidermal growth factor receptor (EGFR) targeted therapies have shown limited efficacy in head and neck squamous cell carcinoma (HNSCC) patients despite its overexpression. Identifying molecular mechanisms associated with acquired resistance to EGFR-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::860886dce60dbfc946b602d59dd174f8
https://doi.org/10.1038/s41598-019-55208-5
https://doi.org/10.1038/s41598-019-55208-5
Autor:
Sneha M. Pinto, Jayshree Advani, Oishi Chatterjee, Yashwanth Subbannayya, T. S. Keshava Prasad, Rajesh Raju, Akhilesh Pandey, Mohan R. Wani, D A B Rex, Aneesha Radhakrishnan
Publikováno v:
Journal of Cell Communication and Signaling. 12:615-624
Interleukin-33 (IL-33) is a member of the IL-1 family of cytokines that play a central role in the regulation of immune responses. Its release from epithelial and endothelial cells is mediated by pro-inflammatory cytokines, cell damage and by recogni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe7f7c924c5c59e513a2f75f3bf2614b
https://doi.org/10.1007/s12079-018-0464-4
https://doi.org/10.1007/s12079-018-0464-4